Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Iroko Pharmaceuticals, LLC
Age
40–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female ≥ \[greater than or equal to\] 40 years of age
If a participant in the previous DIC3-08-05 study, completed the study and did not discontinue for lack of efficacy or safety
Has a diagnosis of OA of the hip or knee with ongoing knee and/or articular hip pain
Is a current chronic user of nonsteroidal anti-inflammatory drugs (NSAIDs) and/or acetaminophen for his/her OA pain and is anticipated to benefit from continuous treatment with therapeutic doses of NSAIDs. A current chronic user is defined as a subject who has used these treatments for ≥ \[greater than or equal to\] 20 days of the last 30 days before screening
You may not be if
Has a known history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any nonsteroid anti-inflammatory drugs (NSAIDs), including diclofenac
Requires chronic use of opioid or opioid combination products to control OA pain of the knee or hip
Has any clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease
Has significant difficulties swallowing capsules or is unable to tolerate oral medication
Clareo Health | Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain
